XKRX:249420 (Korea (the Republic of))
Â
â‚©
11,850
+190 (+1.63%)
Apr 25
What is a stock summary page? Click here for an overview.
Business Description
Ildong Pharmaceutical Co Ltd
ISIN : KR7249420001
Compare
Compare
Traded in other countries / regions
249420.Korea Index Membership
KOSPI IPO Date
2016-08-31Description
Ildong Pharmaceutical Co Ltd is a Korean company which is engaged in manufacturing pharmaceutical products. Its product portfolio includes generic drugs and specialty drugs, such as vitamin supplements, digestive medications, vascular medications, probiotics, topical applications, antihistamines, antipyretics, analgesics, respiratory medications, endocrine medications, psycho-neurological medications, dermatological medications, urologic medications, antibiotics and others. The company also provides raw materials such as synthesizes, probiotics and others.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.41 | |||||
| Equity-to-Asset | 0.27 | |||||
| Debt-to-Equity | 1.28 | |||||
| Debt-to-EBITDA | 6.59 | |||||
| Interest Coverage | 0.82 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.33 | |||||
| Beneish M-Score | -2.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.2 | |||||
| 3-Year EPS without NRI Growth Rate | 75.9 | |||||
| 3-Year Book Growth Rate | -3.6 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 87.86 | |||||
| 9-Day RSI | 75.05 | |||||
| 14-Day RSI | 66.88 | |||||
| 3-1 Month Momentum % | -2.79 | |||||
| 6-1 Month Momentum % | -17.65 | |||||
| 12-1 Month Momentum % | -26.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | |||||
| Quick Ratio | 0.58 | |||||
| Cash Ratio | 0.31 | |||||
| Days Inventory | 84.26 | |||||
| Days Sales Outstanding | 31.66 | |||||
| Days Payable | 48.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.5 | |||||
| Shareholder Yield % | -11.96 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.96 | |||||
| Operating Margin % | 2.14 | |||||
| Net Margin % | -0.74 | |||||
| FCF Margin % | 2.32 | |||||
| ROE % | -2.79 | |||||
| ROA % | -0.76 | |||||
| ROIC % | 2.55 | |||||
| 3-Year ROIIC % | -32.38 | |||||
| ROC (Joel Greenblatt) % | 2.09 | |||||
| ROCE % | 1.76 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 6.95 | |||||
| PE Ratio without NRI | 113.72 | |||||
| PS Ratio | 0.53 | |||||
| PB Ratio | 2.05 | |||||
| Price-to-Tangible-Book | 2.62 | |||||
| Price-to-Free-Cash-Flow | 23.13 | |||||
| Price-to-Operating-Cash-Flow | 11.67 | |||||
| EV-to-EBIT | 85.76 | |||||
| EV-to-EBITDA | 14.42 | |||||
| EV-to-Revenue | 0.73 | |||||
| EV-to-FCF | 30.58 | |||||
| Price-to-GF-Value | 0.66 | |||||
| Price-to-Graham-Number | 3.64 | |||||
| Earnings Yield (Greenblatt) % | 1.16 | |||||
| FCF Yield % | 4.3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ildong Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 614,940.883 | ||
| EPS (TTM) (â‚©) | -202 | ||
| Beta | 1.47 | ||
| 3-Year Sharpe Ratio | -0.95 | ||
| 3-Year Sortino Ratio | -1.21 | ||
| Volatility % | 22.78 | ||
| 14-Day RSI | 66.88 | ||
| 14-Day ATR (â‚©) | 305.419873 | ||
| 20-Day SMA (â‚©) | 11192.5 | ||
| 12-1 Month Momentum % | -26.01 | ||
| 52-Week Range (â‚©) | 10300 - 20500 | ||
| Shares Outstanding (Mil) | 27.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ildong Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ildong Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ildong Pharmaceutical Co Ltd Frequently Asked Questions
What is Ildong Pharmaceutical Co Ltd(XKRX:249420)'s stock price today?
The current price of XKRX:249420 is â‚©11850.00. The 52 week high of XKRX:249420 is â‚©20500.00 and 52 week low is â‚©10300.00.
When is next earnings date of Ildong Pharmaceutical Co Ltd(XKRX:249420)?
The next earnings date of Ildong Pharmaceutical Co Ltd(XKRX:249420) is .
Does Ildong Pharmaceutical Co Ltd(XKRX:249420) pay dividends? If so, how much?
Ildong Pharmaceutical Co Ltd(XKRX:249420) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers